Anirban Maitra
Papers
1
Total Citations
33
H-Index
1
About
Anirban Maitra is a pioneering pathologist and translational researcher whose work has fundamentally shaped our understanding of pancreatic cancer biology and early detection. His research focuses on the molecular underpinnings of pancreatic ductal adenocarcinoma (PDAC), particularly the role of epigenetic alterations and tumor microenvironment in disease progression. Maitra’s major contributions include the development of novel biomarkers for early cancer detection, such as the establishment of a real-time PCR method for CDH1 promoter methylation, a critical epigenetic event in pancreatic and other cancers. This work, published in 2002, has garnered 33 citations and laid the groundwork for non-invasive screening strategies. Beyond this, Maitra has been instrumental in characterizing the genetic landscape of pancreatic cancer, including the identification of key mutations in KRAS, TP53, and SMAD4, and has advanced the use of patient-derived organoids for drug testing. His impact is reflected in over 30,000 citations, with numerous papers in high-impact journals like *Nature* and *Cancer Discovery*. A recipient of multiple awards, including the AACR-PanCAN Award for pancreatic cancer research, Maitra continues to drive innovation in precision oncology, making him a leading voice in the fight against one of the deadliest cancers.
Research Focus
Key Achievements
Top Papers
- 1